GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)
Clinical trial NCT00905255 · COMPLETED
Trial details
- NCT number
- NCT00905255
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-01-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.